Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02860416
Other study ID # ELM-28
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 2016
Est. completion date October 2018

Study information

Verified date June 2019
Source ElMindA Ltd
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).


Description:

To collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).

The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date October 2018
Est. primary completion date September 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 99 Years
Eligibility Inclusion Criteria:

- Completed a BNA test in the past

- Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments.

- Willingness to participate

Exclusion Criteria:

- Significant Sensory deficit

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States ElMindA Glenview Illinois
United States Premier Psychiatric Group Lincoln Nebraska

Sponsors (1)

Lead Sponsor Collaborator
ElMindA Ltd

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary engineering development according to clinical assessments The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes. 2 years
See also
  Status Clinical Trial Phase
Completed NCT02625662 - Facioscapulohumeral Dystrophy in Children